<!-- canonical: https://www.trendhunter.com/trends/institute-for-oneworld-health -->
<!-- robots: noindex -->

# Negelected Virus Vaccines
Institute for OneWorld Health Helps Develop Drugs for Dismissed Diseases

By Elise Ying-Hei Ho | Published 2013-02-22 | Social Good
Source: Trend Hunter, https://www.trendhunter.com/trends/institute-for-oneworld-health
References: [oneworldhealth.org](http://www.oneworldhealth.org/)

Malaria, diarrheal diseases and kala-azar, otherwise known as the black fever, are only some of the various “neglected diseases” the [Institute for OneWorld Health](https://www.trendhunter.com/trends/xaira-therapeutics) has taken on.

New medicines are often patented, which makes reproducing and selling these drugs more difficult, harder to obtain and quite costly in certain parts of the world. As part of the social enterprises initiatives, the Institute for OneWorld Health collaborates with a wide array of institutions including universities, other pharmaceutical labs and foundations to focus on developing drugs and vaccines for diseases that no not affect developed countries as heavily as the developing ones.

Through the social business’s Access Program, the drugs are not only safe and more accessible but also more affordable to those who truly require the medication.

Contact Information
Institute for OneWorld Health [website](http://www.oneworldhealth.org/)
Institute for OneWorld Health [Facebook](http://www.facebook.com/pages/Institute-for-OneWorld-Health/70455065991)
Institute for OneWorld Health [Twitter](http://twitter.com/OneWorldHealth)
Institute for OneWorld Health [LinkedIn](http://www.linkedin.com/company/36290)
Institute for OneWorld Health [YouTube](http://www.youtube.com/user/OneWorldHealth)

## Trend Insights (Trend Hunter)

- Score: 2.7/10
- Popularity: 11% | Activity: 62% | Freshness: 8%
- Audience gender: 50% men, 50% women
- Primary generations: Gen Z, Gen Alpha, Millennial, Gen X
- Top markets: Asia, Africa

## Categories

[Trend Hunter](https://www.trendhunter.com/trends) > [Social Good](https://www.trendhunter.com/socialgood) > [Social Business](https://www.trendhunter.com/socialbusiness)

## Key Themes

### Key Themes Behind This Trend

- **Neglected Diseases:** Disruptive innovation opportunity: Developing drugs and vaccines for neglected diseases that primarily affect developing countries.
- **Affordable Medication:** Disruptive innovation opportunity: Creating more accessible and affordable drugs for people in need.
- **Social Enterprises:** Disruptive innovation opportunity: Collaborating with various institutions to address healthcare issues in underserved regions.

### Where This Applies

- **Pharmaceutical:** Disruptive innovation opportunity: Finding ways to make patented medicines more accessible and affordable in developing countries.
- **Healthcare:** Disruptive innovation opportunity: Developing new strategies and solutions to tackle neglected diseases and improve global healthcare.
- **Social Impact:** Disruptive innovation opportunity: Leveraging social enterprises and collaborative efforts to address health disparities and improve global health outcomes.

## Related on Trend Hunter

- [Health System Improvement Initiatives](https://www.trendhunter.com/trends/health-system-improvement.md)
- [Health-First Funding Initiatives](https://www.trendhunter.com/trends/gilead-sciences.md)
- [Health-Focused Bioplatforms](https://www.trendhunter.com/trends/flagship-pioneering.md)
- [Disability Inclusion-Focused Initiatives](https://www.trendhunter.com/trends/world-health-organizations.md)
- [Child Neglect-Focused Campaigns](https://www.trendhunter.com/trends/sos-childrens-villages-portugal.md)
- [Innovative Vaccine Delivery Systems](https://www.trendhunter.com/trends/innovative-vaccine-delivery.md)
- [Avian Influenza Diagnostic Networks](https://www.trendhunter.com/trends/global-animal-health.md)
- [Community-Supporting Healthcare Platforms](https://www.trendhunter.com/trends/pfizerforall.md)
- [HIV Treatment Research Projects](https://www.trendhunter.com/trends/plantbased-molecules.md)
